Serendipity reveals new method to fight cancer with T cells

2024-11-22T14:40:55-06:00

A promising therapy that treats blood cancers by harnessing the power of the immune system to target and destroy cancer cells could now treat solid tumors more efficiently. Thanks to a recent study from Dan Cappabianca and Krishanu Saha at the Department of Biomedical Engineering and the Wisconsin Institute for Discovery published in Molecular Therapy – Methods & Clinical Development, Chimeric Antigen Receptor (CAR) T-cell therapy can be improved by altering the conditions the T cells are grown in. And it was all discovered by chance.

Serendipity reveals new method to fight cancer with T cells2024-11-22T14:40:55-06:00

Researchers Develop Advanced Gene Editing Techniques to Boost T Cells in Cancer Treatment 

2024-11-14T20:38:46-06:00

A new study from the Krishanu Saha lab suggests using CRISPR technology to optimize natural immune responses by bioengineering and remodeling T cells. Using a multiplexing technique, the team addresses key challenges in current cancer therapies that could significantly improve treatment outcomes. "We have developed a new way to engineer immune cells to fight cancer more safely and effectively. Think of it as reprogramming the body’s own soldiers (T cells) to recognize and attack cancer cells," says Cappabianca.

Researchers Develop Advanced Gene Editing Techniques to Boost T Cells in Cancer Treatment 2024-11-14T20:38:46-06:00

Saha Lab Alumnae Announced JITC Best Immune Cell Therapies and Immune Cell Engineering Paper

2024-11-14T20:47:46-06:00

Katherine P. Meuller, PhD and Nicole J. Piscopo win with “Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression”

Saha Lab Alumnae Announced JITC Best Immune Cell Therapies and Immune Cell Engineering Paper2024-11-14T20:47:46-06:00
Go to Top